0001104659-24-044439.txt : 20240408 0001104659-24-044439.hdr.sgml : 20240408 20240408060410 ACCESSION NUMBER: 0001104659-24-044439 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240408 DATE AS OF CHANGE: 20240408 EFFECTIVENESS DATE: 20240408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genetron Holdings Ltd CENTRAL INDEX KEY: 0001782594 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 001-39328 FILM NUMBER: 24828012 BUSINESS ADDRESS: STREET 1: 1-2/F, BUILDING 11, ZONE 1 STREET 2: NO.8 LIFE SCIENCE PARKWAY CITY: CHANGPING DISTRICT, BEIJING STATE: F4 ZIP: 102206 BUSINESS PHONE: 86 (10) 5090 7500 MAIL ADDRESS: STREET 1: 1-2/F, BUILDING 11, ZONE 1 STREET 2: NO.8 LIFE SCIENCE PARKWAY CITY: CHANGPING DISTRICT, BEIJING STATE: F4 ZIP: 102206 15-12G 1 tm249940d1_1512g.htm 15-12G

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

 

 

FORM 15 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION 

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-39328 

 

 

Genetron Holdings Limited

(Exact name of registrant as specified in its charter) 

 

 

1-2/F, Building 11, Zone 1, 

No.8 Life Science Parkway 

Changping District, Beijing, 102206 

People’s Republic of China 

+86 10 5090-7500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary Shares, par value US$0.0001 per share 

American depositary shares, each representing fifteen (15) Ordinary Shares 

(Title of each class of securities covered by this Form)

 

None 

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains) 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) x
Rule 12g-4(a)(2) ¨
Rule 12h-3(b)(1)(i) x
Rule 12h-3(b)(1)(ii) ¨
Rule 15d-6 ¨

 

Approximate number of holders of record as of the certification or notice date: one

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Genetron Holdings Limited has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: April 8, 2024GENETRON HOLDINGS LIMITED
  
 By: /s/ Sizhen Wang
   Name: Sizhen Wang
   Title: Chief Executive Officer